Research professor in Biodesign; Leader of the Molecular Biosignatures Analysis Unit, ASU
PhD in Chemistry
Alumni Leader Year
Randall Nelson studies diseases that distress human populations and searches for treatments to cure cancer, cardiovascular disease, diabetes, etc. Nelson has published about 100 peer-reviewed manuscripts regarding biological mass spectrometry and proteomics. He holds 22 patents, with 25 more pending, for inventions related to mass-spectrometric technologies and methods. He is president and chief executive officer of Intrinsic Bioprobes, a Tempe-based company he founded to provide protein-analysis services.